Biotechnology - Genomic and Proteomics/IP Profile of Universities working in BGP: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
No edit summary
Line 6: Line 6:
#*Identify these cases and treat them as entities that will also be placed in our mapping device (the quadrants)
#*Identify these cases and treat them as entities that will also be placed in our mapping device (the quadrants)
#* Identify what universities are the “Microsofts” of the field and what companies are the “IBMs” of the field (Use the questionnaire to guide your research when appropriate - Carol will select specific relevant questions)
#* Identify what universities are the “Microsofts” of the field and what companies are the “IBMs” of the field (Use the questionnaire to guide your research when appropriate - Carol will select specific relevant questions)
==Introduction==
American universities are granted over 3,000 U.S. patents each year and maintain a portfolio of over 40,000 patents (see Owen-Smith & Powell, 2003).


<br>
<br>


== Universities and R&D in Biotechnology==
''Note: I have bolded those projects that appear to be experimenting with commons-based approaches. From initial research, it seems that Stanford is the IBM of the university field, UC San Diego is the Microsoft''
''Note: I have bolded those projects that appear to be experimenting with commons-based approaches. From initial research, it seems that Stanford is the IBM of the university field, UC San Diego is the Microsoft''
<br>
<br>


* Stanford
===* Stanford===
** Department of Biochemistry, School of Medicine ([http://biochemistry.stanford.edu/ http://biochemistry.stanford.edu/])
** Department of Biochemistry, School of Medicine ([http://biochemistry.stanford.edu/ http://biochemistry.stanford.edu/])
*** 135 labs in 11 departments
*** 135 labs in 11 departments

Revision as of 17:05, 14 April 2009

Answer the questions:

  1. What are the 5 top Universities in this field?
    • Correlate them with their main outputs (Data. Narratives. Tools)
    • Understand and identify cases where these universities are “experimenting” or “adopting” commons based approach. Are they adopting OA policies, for instance? Are they adopting Social Responsible License approaches?
    • Identify these cases and treat them as entities that will also be placed in our mapping device (the quadrants)
    • Identify what universities are the “Microsofts” of the field and what companies are the “IBMs” of the field (Use the questionnaire to guide your research when appropriate - Carol will select specific relevant questions)

Introduction

American universities are granted over 3,000 U.S. patents each year and maintain a portfolio of over 40,000 patents (see Owen-Smith & Powell, 2003).


Universities and R&D in Biotechnology

Note: I have bolded those projects that appear to be experimenting with commons-based approaches. From initial research, it seems that Stanford is the IBM of the university field, UC San Diego is the Microsoft

* Stanford

Navigation

Bibliography for Item 8 in BGP
Biotechnology_-_Genomic_and_Proteomics